What type of study is this?

This is a Systematic Review study (also classified as: Meta-Analysis).

An initial step toward symptom-based pharmacotherapy for borderline personality disorder: a systematic review and meta-analysis

View Full Paper

Ask AI

Bookmark

Authors

Systematic review compares antipsychotic efficacy in borderline personality disorder, indicating risperidone is most effective.

Risperidone was found to be the most effective medication for borderline personality disorder, especially for anxiety and impulsivity.
The meta-analysis included 21 studies, showing significant effect sizes for risperidone (−1.99), haloperidol (−0.98), and olanzapine (−0.85).
Analysis focused on the efficacy of antipsychotic medications across six symptom domains, such as depression and cognitive impairment.
These findings call for further high-quality trials to validate the efficacy of these medications in treating borderline personality disorder.

Dezfouli et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark